ITGAX and neoplasm: Furthermore, combination therapy increased the frequency of CD11c+ MDSCs in the spleen compared to the tumor-bearing control and cryo-thermal therapy (Figure S4A), which suggested that combination therapy markedly promoted MDSCs to differentiate into macrophages and DCs.